Yao Fei, Wang Jian, Yao Ju, Xu Lei, Qian Junling, Cao Yongke
1 Department of Thoracic Surgery, The Affiliated Jiangning Hospital of Nanjing Medical University , Nanjing, Jiangsu, China .
2 College of International Studies, Nanjing Medical University , Nanjing, Jiangsu, China .
J Laparoendosc Adv Surg Tech A. 2018 Jul;28(7):819-826. doi: 10.1089/lap.2017.0680. Epub 2018 Feb 9.
Anatomic segmentectomy for stage I nonsmall cell lung cancer (NSCLC) has potential advantages such as preserving pulmonary function and reducing postoperative complications. However, many surgeons are deterred from this procedure for its anatomical complexity. Therefore, we presented our early experience with video-assisted thoracoscopic surgery (VATS) anatomic segmentectomy compared with our most recent VATS lobectomy cases.
Forty patients with cT1aN0M0 (ground-glass opacity [GGO] rate >50%) NSCLC underwent VATS segmentectomy from January 2015 to December 2016. To compare the short-term postoperative outcomes, 47 patients, who underwent VATS lobectomy for cT1aN0M0 NSCLC (GGO rate ≤50% and pure solid nodule) during the same period, were referred to as a control group.
The two groups were similar in age, sex, preoperative pulmonary functional assessment, and associated comorbidities. The tumor size in the segmentectomy group was significantly smaller (median, 0.8 cm versus 1.4 cm, P < .001). Segmentectomy and lobectomy groups had similar operating time, estimated blood loss, duration of chest tube drainage, length of postoperative hospital stay, and postoperative major and minor morbidities. With regard to lymph node evaluation, lobectomy was associated with more lymph nodes (median, 12 versus 9 nodes, P < .001) and mediastinal nodal stations evaluated (median, 3 versus 3 stations, P < .001).
With acceptable morbidity and mortality, VATS segmentectomy may be an acceptable option for the treatment of cT1aN0M0 (GGO rate >50%) NSCLC.
对于Ⅰ期非小细胞肺癌(NSCLC),解剖性肺段切除术具有保留肺功能和减少术后并发症等潜在优势。然而,由于其解剖结构复杂,许多外科医生对该手术望而却步。因此,我们展示了与近期电视辅助胸腔镜手术(VATS)肺叶切除术病例相比,我们在VATS解剖性肺段切除术方面的早期经验。
2015年1月至2016年12月,40例cT1aN0M0(磨玻璃密度影[GGO]比例>50%)NSCLC患者接受了VATS肺段切除术。为比较术后短期结果,将同期47例因cT1aN0M0 NSCLC(GGO比例≤50%及纯实性结节)接受VATS肺叶切除术的患者作为对照组。
两组在年龄、性别、术前肺功能评估及合并症方面相似。肺段切除术组的肿瘤大小明显更小(中位数,0.8 cm对1.4 cm,P <.001)。肺段切除术组和肺叶切除术组在手术时间、估计失血量、胸腔引流管留置时间、术后住院时间及术后主要和次要并发症方面相似。在淋巴结评估方面,肺叶切除术与更多的淋巴结(中位数,12个对9个淋巴结,P <.001)及更多的纵隔淋巴结站评估(中位数,3个对3个淋巴结站,P <.001)相关。
在可接受的发病率和死亡率情况下,VATS肺段切除术可能是治疗cT1aN0M0(GGO比例>50%)NSCLC的一个可接受的选择。